These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

531 related items for PubMed ID: 15201963

  • 1. New approaches in the diagnostic procedure of malignant pleural effusions.
    Terracciano D, Di Carlo A, Papa P, Cicalese M, Maietta P, Cecere C, Mariano A, Macchia V.
    Oncol Rep; 2004 Jul; 12(1):79-83. PubMed ID: 15201963
    [Abstract] [Full Text] [Related]

  • 2. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].
    Klech H, Rona G, Hutter C, Bayer PM, Kummer F.
    Wien Klin Wochenschr; 1986 Sep 12; 98(17):564-73. PubMed ID: 3020811
    [Abstract] [Full Text] [Related]

  • 3. Diagnostic value of CA 72-4, carcinoembryonic antigen, CA 15-3, and CA 19-9 assay in pleural fluid. A study of 207 patients.
    Villena V, López-Encuentra A, Echave-Sustaeta J, Martín-Escribano P, Ortuño-de-Solo B, Estenoz-Alfaro J.
    Cancer; 1996 Aug 15; 78(4):736-40. PubMed ID: 8756365
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of seven tumour markers in pleural fluid for the diagnosis of malignant effusions.
    Miédougé M, Rouzaud P, Salama G, Pujazon MC, Vincent C, Mauduyt MA, Reyre J, Carles P, Serre G.
    Br J Cancer; 1999 Nov 15; 81(6):1059-65. PubMed ID: 10576665
    [Abstract] [Full Text] [Related]

  • 5. Soluble oncoprotein 185HER-2 in pleural fluid has limited usefulness for the diagnostic evaluation of malignant effusions.
    Porcel JM, Salud A, Vives M, Esquerda A, Rodríguez-Panadero F.
    Clin Biochem; 2005 Nov 15; 38(11):1031-3. PubMed ID: 15925354
    [Abstract] [Full Text] [Related]

  • 6. Clinical utility of a combination of tumour markers in the diagnosis of malignant pleural effusions.
    Gaspar MJ, De Miguel J, García Díaz JD, Díez M.
    Anticancer Res; 2008 Nov 15; 28(5B):2947-52. PubMed ID: 19031938
    [Abstract] [Full Text] [Related]

  • 7. The diagnostic usefulness of tumour markers CEA and CA-125 in pleural effusion.
    Sthaneshwar P, Yap SF, Jayaram G.
    Malays J Pathol; 2002 Jun 15; 24(1):53-8. PubMed ID: 16329556
    [Abstract] [Full Text] [Related]

  • 8. Diagnostic value of three tumor markers determined in pleural effusions.
    Conejo JR, Benedito JE, Jimenez A, Menchen M, Cano J, Granizo V, Larrodera L.
    Eur J Clin Chem Clin Biochem; 1996 Feb 15; 34(2):139-42. PubMed ID: 8833646
    [Abstract] [Full Text] [Related]

  • 9. Carcinoembryonic antigen (CEA) levels in pleural effusions and sera of lung cancer patients.
    Ogushi F, Fukuoka M, Takada M, Tamai S, Sakai N, Negoro S, Okunaka N, Sone S, Tsubura E.
    Jpn J Clin Oncol; 1984 Sep 15; 14(3):321-7. PubMed ID: 6090732
    [Abstract] [Full Text] [Related]

  • 10. Diagnostic significance of cancer antigen 125, pancreatic oncofetal antigen, and carcinoembryonic antigen in malignant and tuberculous pleural effusions.
    Niwa Y, Shimokata K.
    Jpn J Clin Oncol; 1986 Mar 15; 16(1):3-8. PubMed ID: 3009919
    [Abstract] [Full Text] [Related]

  • 11. Performance of CEA and CA19-9 in identifying pleural effusions caused by specific malignancies.
    Hackbarth JS, Murata K, Reilly WM, Algeciras-Schimnich A.
    Clin Biochem; 2010 Sep 15; 43(13-14):1051-5. PubMed ID: 20529669
    [Abstract] [Full Text] [Related]

  • 12. Clinical value of CYFRA21-1, NSE, CA15-3, CA19-9 and CA125 assay in the elderly patients with pleural effusions.
    Li CS, Cheng BC, Ge W, Gao JF.
    Int J Clin Pract; 2007 Mar 15; 61(3):444-8. PubMed ID: 17313612
    [Abstract] [Full Text] [Related]

  • 13. Clinical evaluation of four tumor markers in malignant and benign pleural effusions.
    Toumbis M, Chondros K, Ferderigos AS, Daganou M, Dema A, Dalamaga A, Kakari S, Stringou E.
    Anticancer Res; 1992 Mar 15; 12(4):1267-70. PubMed ID: 1503419
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of CYFRA 21-1 in malignant and benign pleural effusions.
    Toumbis M, Rasidakis A, Passalidou E, Kalomenidis J, Alchanatis M, Orphanidou D, Jordanoglou J.
    Anticancer Res; 1996 Mar 15; 16(4A):2101-4. PubMed ID: 8712750
    [Abstract] [Full Text] [Related]

  • 15. [Diagnostic utility of carcinoembryonic antigen, neuron-specific enolase and squamous cell carcinoma antigen in malignant pleural effusion].
    Sánchez de Cos Escuín J, López Parra S, Disdier Vicente C, Martín Vicente MJ, Masa Jiménez JF, Domínguez Retortillo C.
    An Med Interna; 1996 Aug 15; 13(8):369-73. PubMed ID: 8983362
    [Abstract] [Full Text] [Related]

  • 16. Diagnostic value of CYFRA 21-1, CEA, CA 19-9, CA 15-3, and CA 125 assays in pleural effusions: analysis of 116 cases and review of the literature.
    Shitrit D, Zingerman B, Shitrit AB, Shlomi D, Kramer MR.
    Oncologist; 2005 Aug 15; 10(7):501-7. PubMed ID: 16079317
    [Abstract] [Full Text] [Related]

  • 17. Tumor type M2-pyruvate-kinase levels in pleural fluid versus plasma in cancer patients: a further tool to define the need for invasive procedures.
    Elia S, Massoud R, Guggino G, Cristino B, Cortese C, De Massimi AR, Zenobi R.
    Eur J Cardiothorac Surg; 2008 Apr 15; 33(4):723-7. PubMed ID: 18261916
    [Abstract] [Full Text] [Related]

  • 18. [Tumor markers in pleural effusion of patients with lung cancer and patients with tuberculous pleurisy].
    Tada A, Kawai H, Matsumoto H, Kimura G, Okada C, Soda R, Takahashi K.
    Nihon Kokyuki Gakkai Zasshi; 2002 Feb 15; 40(2):106-12. PubMed ID: 11974864
    [Abstract] [Full Text] [Related]

  • 19. [Clinical evaluation of various tumor markers in pleural effusion and in the serum].
    Jibiki K, Abe Y, Takeda M, Iwachika C, Odagiri E, Demura R, Demura H.
    Gan No Rinsho; 1989 Aug 15; 35(9):991-8. PubMed ID: 2769951
    [Abstract] [Full Text] [Related]

  • 20. Value of human chorionic gonadotropin compared to CEA in discriminating benign from malignant effusions.
    Lamerz R, Stoetzer OJ, Mezger J, Brandt A, Darsow M, Wilmanns W.
    Anticancer Res; 1999 Aug 15; 19(4A):2421-5. PubMed ID: 10470169
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.